Nanomedicine: Transforming Neurological Therapies and Precision Medicine
Nanomedicine is going to be a novel and different avenue of therapy for the neurological patients, overcoming blood-brain barrier difficulties while also addressing the unique complexity of neurological diseases. With applications of nanoparticles, including liposomes, dendrimers, exosomes, and polymeric nanoparticles, effective drug delivery will be possible via targeted and controlled release and reduced adverse effects. These technological breakthroughs are going to be of great help in the treatment of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's, and in conditions like multiple sclerosis. Because of this, nanomedicine has a great promise in the field of neuroinflammatory conditions as well. In addition, nanomedicine is going to play a significant role in precision medicine, where therapies can be planned according to the genetic, molecular, and biological makeup of the patients. However, precision in diagnosis and monitoring will also provide a personalized treatment regimen as nanotechnology can be integrated with other advanced diagnostic technologies like MRI, PET, and biomarker detection. Although it has a lot of promise, clinical translation has not avoided the same problems that have proved to be highly disconcerting for so many developments in nanomedicine, including issues of biocompatibility, safety, and, in the case of some products, regulatory approval. Addressing these factors will prove critical for the successful embedding of nanomedicine into the routine neurological care system. This review touches on the current status of nanomedicine in neurology, the promise that it holds for precision treatments, and the barriers that apply to its ability to effect real clinical practice portrayals, thereby providing an insight into the future of personalized therapy in neurology.
DOI: 10.29245/2572.942X/2025/1.1311 View / Download PdfEnhancing Intracranial Aneurysm Detection with Artificial Intelligence in Radiology
Intracranial aneurysms (IAs) pose a significant public health challenge due to their potential for rupture and associated morbidity and mortality. Despite advancements in imaging technologies such as magnetic resonance angiography (MRA) and computed tomography angiography (CTA), detecting small, incidental IAs remains challenging, particularly amid increasing global imaging volumes and resource constraints. Artificial intelligence (AI) has emerged as a transformative tool in medical imaging, demonstrating potential to enhance diagnostic accuracy and efficiency. Deep learning models, particularly convolutional neural networks (CNNs), have shown near-expert accuracy in detecting subtle aneurysmal features, enabling early diagnosis and improving clinical workflows. AI-driven approaches extend beyond detection to include rupture risk assessment, predictive diagnostics, and treatment planning, thereby improving patient-specific care and reducing unnecessary interventions.
However, challenges such as false-positive rates, ethical considerations, and the need for robust validation studies hinder AI adoption in clinical practice. This review contextualizes recent advancements and the findings of Adamchic et al. (2024), within the broader landscape of AI applications in IA diagnostics. It discusses AI’s role in addressing diagnostic variability, mitigating radiologist workloads, and enhancing reproducibility, particularly for junior clinicians. The article also explores barriers to widespread implementation, including data safety, algorithm transparency, and financial constraints, while emphasizing the need for collaborative efforts to refine AI models and integrate them seamlessly into radiology workflows. By addressing these challenges, AI has the potential to revolutionize intracranial aneurysm management, improving patient outcomes and transforming modern radiology practices.
DOI: 10.29245/2572.942X/2025/1.1310 View / Download PdfEpistemological Approach to the “Visual Perception” Concept Applied to Medicine
Objective: This study aims to analyze the limitations of human visual perception, compare them with the visual adaptations of other species, and explore how technological advancements—such as artificial intelligence, medical imaging, and augmented reality—have improved medical diagnostics and surgical precision.
Methods: A structured literature review was conducted, incorporating comparative analyses of visual perception across species, including frogs, dragonflies, and humans. The study evaluated the role of advanced imaging technologies, artificial intelligence-based diagnostics, and digital image processing tools in overcoming the limitations of biological vision. Selection criteria for species comparisons were based on functional adaptations and their relevance to medical imaging applications.
Results: Findings indicate that species-specific visual adaptations are optimized for survival rather than accuracy. Human vision, while advanced, is inherently constrained by physiological and neurological limitations. However, medical imaging technologies, including fluorescence-guided surgery, histology, and AI-assisted diagnostics, have significantly enhanced the precision of visual interpretation in clinical settings. The integration of computational tools, such as Adobe Photoshop for forensic and radiological analysis, further refines image accuracy and medical decision-making.
Conclusion: The interplay between biological vision and technological advancements underscores the necessity of integrating artificial intelligence and advanced imaging in medical practice. Future research should focus on optimizing these technologies to further enhance diagnostic accuracy, surgical precision, and clinical outcomes, ultimately pushing the boundaries of human visual perception.
DOI: 10.29245/2572.942X/2025/1.1309 View / Download Pdf